Barclays’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,900
Closed -$117K 5560
2020
Q2
$117K Buy
+1,900
New +$77.6K ﹤0.01% 4413
2019
Q4
Sell
-140,000
Closed -$3.61M 6784
2019
Q3
$3.61M Buy
140,000
+100,000
+250% +$3.04M ﹤0.01% 2171
2019
Q2
$1.18M Hold
40,000
﹤0.01% 3518
2019
Q1
$1.37M Buy
+40,000
New +$1.42M ﹤0.01% 3049

Other funds holding STAA

Barclays's STAA Position: Q1 2026 in Review

Barclays reduced its STAAR Surgical (STAA) stake by 92% in Q1 2026, selling an estimated $1.36M and leaving 6,588 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #3938.

Barclays first reported a position in STAA in Q2 2013 and has held it in 50 quarters since. The position peaked at $22.4M in Q4 2021. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Barclays held 6,588 shares of STAAR Surgical worth $123K as of Q1 2026.
  • Barclays sold 71,251 STAAR Surgical shares in Q1 2026, an estimated $1.36M.
  • STAAR Surgical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3938 holding.
  • Barclays first reported a position in STAAR Surgical in Q2 2013 and has held it in 50 quarters since.
  • Barclays's STAAR Surgical position peaked at $22.4M in Q4 2021.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.